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Abstract The objective of this study was to compare  the ef- 
fects of linoleic acid (cis,cis-C18:2(n-6)) and its hydrogena- 
tion products elaidic (transClS:l(n-9))  and stearic acid 
(C18:O) on serum lipoprotein levels in humans. Twenty-six 
men  and 30 women, all normolipemic and apparently heal- 
thy, completed  the trial. Three  experimental  diets were sup  
plied to every subject for 3 weeks each, in random order 
(multiple cross-over). The Linoleate-diet provided 12.0% of 
total energy intake as linoleic acid, 2.8% as stearic acid, and 
0.1 % as trans fatty acids. The  Stearatediet  supplied 3.9 ener- 
gy % as linoleic acid, 11 .S% stearic acid, and 0.3% trans fatty 
acids. The  Transdiet provided 3.8 energy % as linoleic acid, 
3.0% stearic acid, and 7.7% as monounsaturated trans fatty 
acids, largely elaidic acid (trans-Cl8:l (n-9)). Other nutri- 
ents were constant. Fasting blood was sampled at  the  end of 
each dietary period. Mean ( f SD) serum LDL cholesterol 
was 109 f 24 mg/dl (2.83 f 0.63 mmol/l)  on  the Linoleate- 
diet.  It rose to 116 f 27 mg/dl (3.00 10.71  mmol/l)  on  the 
Stearate-diet (change, 7 mg/dl or 0.17 mmol/l, P =  0.0008) 
and  to 119 k 25  mg/dl (3.07 f 0.65 mmol/l)  on  the Trans- 
diet (change, 9 mg/dl or 0.24 mmol/l, P <  0.0001). High 
density lipoprotein  (HDL) cholesterol  decreased by 2 mg/dl 
(0.06 mmol/l, P <  0.0001) on the Stearate-diet and by 4 
mg/dl (0.10 mmol/l, P< 0.0001) on the Transdiet, both 
relative to linoleic acid. Our findings show that 7.7% of 
energy (mean, 24 g/day) of trans fatty acids  in the  diet sig- 
nificantly lowered HDL cholesterol and raised LDL choles- 
terol relative to linoleic acid. Combination with earlier 
results (Mensink, R. P., and M. B. Katan. 1990. N. Engl. J. 
Med. 323: 439-445) suggests a linear dose-response relation. 
Replacement of linoleic acid by stearic acid also caused 
somewhat lower HDL cholesterol and  higher LDL cholester- 
ol levels. Hydrogenation of linoleic acid to  either 
stearic or irans fatty acids produces fatty acids that may in- 
crease LDL and decrease HDL cholesterol relative to 
linoleic acid itself.-Zock, P. L., and M. B. K a t a n .  Hydro- 
genation alternatives: effects of trans fatty acids and stearic 
acid versus linoleic acid on  serum lipids and  lipoproteins in 
humans. J. Lipid R e s .  1992. 33: 399-410. 
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Monounsaturated trans fatty acids with a length of 
18 carbon atoms are  formed when vegetable oils, rich 
in linoleic acid, are partially hydrogenated to produce 
fats  with better  texture and stability (1). Although the 
intake of these trans fatty  acids,  mainly elaidic acid and 
its isomers (Fig. l ) ,  is much lower than  that of 
saturated fatty acids, it is still considerable in in- 
dustrialized countries. Estimated average consumption 
of trans fatty acids is 34% of  daily energy intake in the 
United States (2). 
Early studies on the effects of trans fatty acids on 
blood lipids produced conflicting results. Some studies 
(3-5) suggested that trans fatty acids, as compared  to 
their cis isomer oleic acid, elevate serum total choles- 
terol levels,  while others (6-8) could not confirm this. 
In a previous study conducted at our Department it 
was found  that trans monounsaturated fatty acids were 
hypercholesterolemic compared with oleic acid, and 
that their effect was about half that of a mixture of 
saturated fatty acids (C12:0, C14:0, and C16:O) (9). In 
this study trans fatty acids not only raised the serum 
level of atherogenic low density lipoprotein (LDL) 
cholesterol, but also lowered high density lipoprotein 
(HDL) cholesterol (9). However, the  amount of trans 
fatty acids given was quite high (1 1% of daily energy 
intake), and doubts have been voiced as to whether 
these findings could be extrapolated to lower  levels  of 
intake (10). 
A product of further hydrogenation of linoleic acid 
(Fig. 1) is stearic acid, the completely saturated ana- 
logue of elaidic acid. Stearic acid has been  found  not 
to raise the serum cholesterol level  relative to car- 
bohydrates and to  exert effects on serum lipids similar 
to those of oleic acid (11-14). Like trans fatty acids 
and other saturated fatty acids, stearic acid is a rigid 
molecule whose presence adds firmness to foods. Al- 
though stearic acid has a higher melting point than 
trans fatty acids or palmitic acid (C16:O) and has a 
Abbreviations; HDL, high density lipoproteins; LDL, low density 
'To  whom correspondence  should be  addressed. 
lipoprotein. 
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LINOLEIC ACID 'OH 
+LH 
TRANS-C18 l (n - I0 ) /A8  'OH 
TRANS-C18.1 "-----C:o (n-9) /A9 
OH 
(ELAIDIC ACID) 
TRANS-C18-l ( n  -8)/A10 \OH 
STEARIC ACID \OH 
Fig. 1. Structure of linoleic acid and of some products of 
hydrogenation. Partially hydrogenated soybean oil usually contains 
a spectrum of positional transC18:l isomers with C18:l (n-8) (A'') 
being the most abundant (31). 
waxy nature,  a limited increase in the stearic acid con- 
tent at the expense of other saturated fatty acids or 
trans fatty acids has been suggested as a way for the 
edible-fats industry to produce semi-solid and solid fats 
with  less  of a cholesterol-raising potential (15). 
Therefore we compared the effects of trans fatty 
acids on serum lipoprotein and apolipoprotein levels 
in healthy men and women  with those of stearic acid 
and of linoleic acid, the  parent fatty  acid from which 
trans  fatty  acids and stearic acid are derived during  the 
hydrogenation of  soybean and  other linoleic acid-rich 
oils. 
SUBJECTS AND METHODS 
Subjects 
Out of 110 persons who responded  to calls  via  local 
newspapers, 45 women and 42 men were randomly 
selected for a screening procedure. Two women and 1 
man were excluded for medical reasons and 2 men 
and 2 women  withdrew during the screening. The 
remaining 80 volunteers, 39 men and 41 women, had 
no history of atherosclerotic disease, and all were ap- 
parently healthy, as indicated by a medical question- 
naire. None had anemia, glycosuria, proteinuria, or 
hypertension, and  none were taking medications 
known to affect blood lipids.  Because  only 62 subjects 
could be enrolled in the trial, 31 men and 31 women 
were randomly selected to take part.  Three men 
withdrew before the study began. The protocol and 
aims of the study  were  fully explained to the subjects, 
who gave their written consent. No reward was given, 
except for the free food in the study diets. Approval 
for the study had  been  obtained from the Ethics  Com- 
mittee of the Department. During the study 2 men 
withdrew, one because of personal reasons and one 
because of illness. One woman withdrew because of 
pregnancy. All analyses are based on the 26 men and 
30 women who completed the trial. Before the begin- 
ning of the study diets, the subjects'  fasting serum lipid 
levels ranged from 3.31 to 6.66 mmol/l for total cho- 
lesterol (mean, 4.84 mmol/l or 187.2 mg/dl), from 
0.87  to  2.04 mmol/l for HDL cholesterol (mean, 1.38 
mmol/l or 53.4 mg/dl),  and from 0.39 to 1.58 mmol/l 
(mean, 0.94 mmol/l or 83.2 mg/dl)  for triglycerides. 
The men's age ranged from 19 to 48 years (mean, 25 
years),  and they weighed between  60 and 84 kg (mean 
73 kg). Their body mass index ranged from 18.5 to 
26.0  kg/m' (mean, 21.5 kg/m'). The women  were  be- 
tween 18 and 49  years old (mean, 24 years),  and 
weighed between 51 and 80 kg (mean, 63 kg); their 
body mass index  ranged from 17.9 to 27.5 kg/m2 
(mean, 21.5 kg/m'). Thirteen women used oral con- 
traceptives, and  4 men and 4 women smoked. 
Design and statistical analyses 
The trial ran from January 29 until April 2, 1990. 
The study had a multiple crossover design and con- 
sisted of three consecutive periods. Each subject fol- 
lowed the three study diets for 3 weeks each. Our 
experience agrees with that of earlier workers (1 1, 16) 
in that serum lipid and lipoprotein levels  tabilize 
within 2 weeks after a dietary change (17, 18). One 
diet was high in linoleic acid (Linoleate-diet), one was 
high in stearic acid (Stearatediet),  and the third was 
high in elaidic acid (Transdiet). Before the trial, the 
participants were categorized according to sex. Male 
and female subjects  were then divided into six groups 
so that each group  had  a nearly identical number of 
subjects from both sexes. Women who used oral con- 
traceptives were  equally distributed over the six treat- 
ment sequences. Each group received the diets in a 
different order (Fig. 2). In this way, variation due to 
residual effects of the previous diet or to drift of  vari- 
ables over  time  were eliminated (19). We attempted to 
blind the participant as to the  sequence of their diets, 
PERIOO SUBJECTS 
GROUP 
1 
D IET  
2 
DIET 
3 MEN WOMEN 
DIET N.26 N-30 
1 I LINOLEATE TRANS 1 m  
2 [ LINOLEATE I TRANS 
3 mSfEARATE//h LINOLEATE I TRANS ] m 1  
L ~STEARATE~/A TRANS [ LINOLEATE 1 m\ 
5 1 TRANS 1 LINOLEATE F%S,TE,ARAfEm 
6 I TRANS F@,TEARAJE:,$i;,j LINOLEATE 1 12[61 
3 WEEKS 3 WEEKS 3 WEEKS 
SAMPLING 
BLOOD 
Fig. 2. Experimental design. 
t t   t t   1 1  
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but at  the end of the trial it turned  out  that all subjects 
had recognized the linoleic acid-rich diet, and most of 
them  had also correctly identified the trans and stearic 
acid-rich diets. However, it is highly  unlikely that 
awareness of the  nature of the  treatment  could have 
affected the  outcome of the study. 
The data were analyzed with the General Linear 
Models  (GLM)  of the Statistical  Analyses  System (20). 
When the analyses indicated a significant effect of diet 
( P <  0.05), the Tukey method was used for painvise 
comparisons of the diets and for calculation of 95% 
confidence limits for  the differences between two diets 
(20). This method encompasses a downward adjust- 
ment of significance limits for multiple testing and, as 
a result, only  P-values  of  less than 0.02  were considered 
significant. 
Diets 
Before the trial started, the participants recorded 
their habitual diet  for 2 working days and 1 weekend 
day to allow us to estimate their energy and  nutrient 
intake. The food  records were coded  and  the  nutrient 
composition and energy content of the diets were  cal- 
culated with use of the Netherlands Nutrient Data 
Base (21). The study diets consisted of conventional 
solid foods, and menus were changed daily during 
each %week cycle. The planned nutrient content of 
the  three  diets was similar, except for 8% of total ener- 
gy, which was provided by linoleic acid, stearic acid, or 
elaidic acid. The linoleate group received a commer- 
cially  available margarine high in linoleic acid (Becel, 
Van den Bergh foods, Rotterdam, The Netherlands). 
In addition, high-linoleic acid sunflower oil was used 
in the preparation of various dishes. For the Trans 
diet, high-oleic  a id sunflower oil (Trisun, SVO 
Enterprises, Wickliffe, OH) was hydrogenated with a 
sulfurized nickel catalyst (Pricat 9908, Unichema, Em- 
merich, Germany) under conditions that favored for- 
mation of trans rather  than saturated fatty  acids. This 
hydrogenation procedure was similar to that applied 
for our previous study (9, 22). We used this procedure 
rather  than hydrogenation of a linoleic acid-rich oil to 
avoid the formation of trans-isomers of C18:2 and to 
maximize the yield  of trunsC18:l. Seventy-five parts of 
the  hydrogenated  fat were mixed with  25 parts of the 
unaltered oleic acid-rich oil, and used to produce a 
margarine and a shortening high in elaidic acid. Fats 
for the Stearate-diet were produced by interesterifica- 
tion of a mixture of 41 parts of fully hydrogenated 
high-linoleic acid sunflower oil (Chempri, Raams- 
donksveer, The Netherlands), 50 parts of high-oleic 
acid sunflower oil, and 9 parts unmodified of high- 
linoleic acid sunflower oil. 
Thus,  the basic source of  all  fatty acids in which the 
three diets differed was sunflower oil. The special  mar- 
garines and shortenings were developed and manufac- 
tured by the Unilever Research Laboratory 
(Vlaardingen, The Netherlands). Table 1 gives the 
fatty acid composition of margarines and oil used in 
the  three diets. Positional isomers of monounsaturated 
C18:l-fatty acids were identified by gas-liquid chroma- 
tography using a capillary Sil-88 column. 
The diets were formulated at 24  levels  of energy in- 
take ranging  from 5.5 to 17.5 MJ (1315 to 4185  kcal) 
per day. All foodstuffs were weighed out for each in- 
dividual subject. On week days at noon, hot meals 
were served and eaten at the department. All other 
food was supplied daily as a package. Food for the 
weekend and guidelines for its preparation were 
provided on Fridays. In  addition  to  the food supplied, 
subjects were  allowed a limited number of items free 
from fat and cholesterol. The energy intake from 
these free-choice items was fixed for each level  of ener- 
gy intake and ranged from 7 to 13% of total energy in- 
take. Subjects were urged not to change  their selection 
of free-choice items throughout the trial. They were 
asked to maintain their usual pattern of physical ac- 
tivity and not to change their smoking habits, con- 
sumption of coffee, or use of oral contraceptives. The 
participants recorded in diaries any sign of illness, 
medication used, the selection and use of free-choice 
items, the  amount  and type of coffee consumed, and 
any deviations from  their diets. Inspection of the 
diaries did  not reveal  any deviations from the protocol 
that might have affected the results. Duplicate por- 
tions of each study diet were collected on each of the 
63 trial days for  an imaginary participant with a daily 
energy intake of 11 MJ (2630 kcal), stored at -20°C, 
TABLE 1. Fatty acid composition of the margarines and oil used 
in the three study diets 
Fatty  Acid Linoleate-Diet Stearate-Diet TmnsDiet 
g per 100 g of fatty acid 
Saturated 18.1 52.9  12.  
Lauric acid (C12:O) 1.5 0.1 0.0 
Myristic acid (C140) 0.6 0.1 
Palmitic acid (C160) 7.6  5.6 
0.0 
3.6 
Stearic acid (C18:O)  7.0 45.5 6.6 
Monounsaturated 18.8 37.4 
CzsC18:l 
84.2 
18.4  37.0  43.6' 
TmnsC18:l 0.1  0.1  40.2' 
Linoleic acid 
TrancC18:P 
Polyunsaturated 62.5  9.5  2.1 
1.9 
0.5 0.0 0.2 
Others 0.5  0.2  1.6 
(cis,clsc18:2) 61.9 9.4 
oil provided 37% of the total fat content of the Linoleatediet, high-stearic 
Commercially available linoleic acid-rich margarine and regular sunflower 
acid margarine and  shortening provided 48% of the total fat content of the 
Stearate-diet, and  highelaidic acid margarine and  shortening provided 44% of 
the total fat content of the Tmncdiet. 
g; C18:l(n-7), 1.3g; ClS:l(n-9), 38.5 g; C18:l(n-12), 3.1  g. 
'Positional cisisomers: ClS:l(n-l), 0.1 g; C18:l(n-5), 0.2 g; C18:(n-6), 0.4 
(elaidic acid) plus traces ofC18l(n4)(A1')  and C18:1(n-10)(A8). 
bGLC showed three positional isomers, predominantly C18:I (n-9) (A') 
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and pooled and analyzed after the study. These 
analyzed values of the food supplied were combined 
with the values for  the free-choice items (See Table 2). 
Body weights without shoes, jackets, and heavy 
sweaters  were recorded twice  weekly. The level  of ener- 
gy intake was adjusted when necessary, as indicated by 
weight changes. Over the  63 days of the trial average 
body weight fell by 0.2 f 1.1 kg (range, -2.5 to +2.0 
kg).  The mean difference in body weight at  the  end of 
the dietary periods was 0.1 k 0.7 kg (range -1.7 to 1.4 
kg) between the Linoleate-diet and the Stearate-diet, 
0.0f 0.8 kg (range -2.1  to 1.8 kg) between the 
Linoleate-diet and the Trunsdiet, and 0.1 f 0.7 kg 
(range -1.8 to 2.4 kg) between the Tran.Fdiet and the 
Stearate-diet. 
Blood sampling and  analyses 
Before the trial each participant  had  been assigned 
a random number that was then used for labeling 
blood and serum tubes. In this way the laboratory 
technicians were kept unaware of the subject's diet se- 
quence. Blood samples were taken after a 12-h  fast on 
days 1, 17, and 21 (period l ) ,  days 38 and 42 (period 
2 ) ,  and on days 59 and 63 (period 3). All venipunc- 
tures of each subject were performed by the same 
technician, in the same location, and  at  the same time 
of the same day of the week. Serum was obtained by 
low-speed centrifugation within 1 h of venipuncture, 
stored at -8O"C, and analyzed enzymatically for total 
and HDL cholesterol and triglycerides (23, 24). All 
samples from a  particular subject were analyzed within 
the same run.  The coefficient of variation within runs 
was 1.5% for total cholesterol, 1.6% for HDL choles- 
terol, and 2.9% for triglycerides. Mean  bias  with 
regard to the target values of three serum pools pro- 
vided by the  Centers  for Disease Control (Atlanta, GA) 
(25) was 0.14 mmol/l for total cholesterol and 0.04 
mmol/l  for triglycerides. The mean bias  with regard to 
target values of four serum pools obtained from the 
Solomon Park Research Laboratories (Kirkland, WA) 
was 0.09 mmol/l  for HDL cholesterol. L,DL cholesterol 
was calculated using the Friedewald equation (26). 
Apolipoproteins were assayed by Dr. M. Sandkamp at 
the Institut fur Klinische Chemie and Laborator- 
iumsmedizin, Munster, Germany (Head: Prof. Dr. G. 
Assmann), using a  turbidimetric  method  on microtiter 
plates, as described (27). All samples from the same 
proband were measured on the same day within one 
series. The coefficient of variation within the series was 
3.5% for  apolipoprotein A-I and 3.6% for apolipc- 
protein B. The two lipoprotein and apolipoprotein 
values obtained  at  the  end of each dietary period were 
averaged for  data analyses. 
For each subject, the fatty acid composition of 
serum cholesteryl esters was determined in samples ob- 
tained at  the  end of each dietary period (days  21, 42, 
and 63) as described earlier (28), with the following 
modifications: cholesteryl esters and triglycerides were 
separated with Bond-Elut solid phase extraction 
columns (Analytichem International,  Harbor City, 
CA), the  component fatty acids were methylated with 
4% (v/v) H2S04 in methanol, and a capillary Sil-88 
column was used for gas chromatographic analysis. 
The results are expressed as a  proportion by weight of 
all  fatty acids detected. 
RESULTS 
Diets and dietary  adherence 
The mean daily intakes of energy and the composi- 
tion of the  three  experimental  diets as determined by 
chemical analyses of duplicate diets plus calculated 
contribution of freechoice items are given in Table 2. 
Energy and nutrients supplied by the free-choice items 
(mainly carbohydrates and some alcohol and  protein) 
did not differ between the dietary regimes. The intake 
of protein, carbohydrates, alcohol,  cholesterol, phyto- 
sterols, and fiber did not change  throughout  the study. 
Total fat intake  differed somewhat between the  Trans 
diet and  the Stearate-diet (3.8 energy %) due  to small 
differences in the intake of oleic acid (cis-Cl8:l) and 
saturated fatty acids (C12:0, C14:0, C16:0), and also 
due to the fact that  he  difference in stearic acid 
(C18:O) intake turned out to be 8.8% of energy in- 
stead of the  planned 8%. The percentage of total daily 
energy from linoleic acid decreased from 12.0% on 
the Linoleate-diet to 3.9% and 3.8% on the Stearate- 
and Trunsdiets, respectively. It was replaced by 9.0% 
stearic acid on  the Stearate-diet and by 7.6% monoun- 
saturated trans  fatty acids on  the Transdiet. At an  ener- 
gy intake of 1 l MJ (2630 kcal) per day the Trunsdiet 
provided 8.7 g of stearic and 22.2 g of trans  fatty acids 
(trunsC18:l)  per day, while the Stearate-diet supplied 
34.2 g of stearic acid and 0.8 grams of trans  fatty acids. 
Gas-liquid chromatography revealed three position- 
al isomers of trunsC18:l in the trans fatty acids-rich 
margarine and shortening; predominantly truns- 
C18:l(n-9) (A!') (elaidic acid) and minor amounts of 
trunsC18:l (n-10) (A8) and trunsC18:l (n-8) (A'"). 
The fatty acid composition of the serum cholesteryl 
esters at the end of the three dietary periods con- 
firmed  the subjects' adherence to the  diets (Table 3). 
In 54 out of the 56 subjects the  proportion of linoleic 
acid in  the  cholesterol esters was higher  on  the 
Linoleate-diet than  oeither  the Stearate-diet 
(average change, 6.60 g/100  g;  95%  confidence  inter- 
val, 5.87 to 7.33) or the Truns-diet (average change, 
8.17 g/100 g; 95% confidence interval, 7.44 to 8.99). 
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TABLE 2. Mean daily intake of nutrients of subjects while on the  high-linoleic  acid diet, the high-stearic 
acid diet, and  the  high-h-ans  fatty  acid diet 
____ 
Energy/Nutrient 
~ 
Linoleate-Diet  Stearate-Diet  Trans-Diet 
Energy 
MJIday 
kcal/day 
Protein (% of energy) 
Fat (% of energy) 
Saturated  fatty  acids 
Lauric acid (C12:O) 
Myristic acid (C14:O) 
Palmitic acid (C160) 
Stearic acid (C18:O) 
C i K  18: 1 
T~unSC18: 1 
Linoleic acid (cis,cisC18:2) 
TransC18:Z 
Monounsaturated  fatty  acids 
Polyunsaturated  fatty  acids 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol (mg/MJ) 
PSitosterol (mg/MJ) 
Other  plant  sterols (mg/MJ) 
Dietary fiber (g/MI) 
12.0 f 2.8 
2869 f 670 
12.3 
41.1 
11.0 
0.7 
0.9 
5.8 
2.8 
15.8 
14.7 
0.1 
12.5 
12.0 
0.0 
46.0 
0.9 
33.5 
23.8 
3.0 
3.6 
11.9 f 2.7 
2845 f 646 
12.3 
43.5 
20.1 
0.5 
1.0 
5.7 
11.8 
16.6 
15.4 
0.3 
4.3 
3.9 
0.0 
43.5 
0.9 
32.6 
25.1 
3.9 
3.9 
12.0+ 2.7 
2869 f 646 
12.8 
39.7 
10.3 
0.5 
1.0 
4.8 
3.0 
23.3 
14.6 
7.7" 
4.2 
3.8 
0.0 
46.6 
1.0 
33.5 
22.6 
3.0 
4.0 
Values are based on chemical analyses of duplicate diets plus the calculated contribution of free-choice items (see 
Methods). Each  value  represents  the  mean of three independent duplicates collected in  three  different  periods  during  which 
each diet was consumed by one-third of the  subjects.  Variations  between periods were negligible. 
"Values  for  total  trans  fatty  acid content as determined by gas-liquid  chromatography  (GLC)  and by infrared  spectroscopy 
(IR) were  similar:  both GLC and IR indicated 20.2 g of trans  fatty acids  per 100 g of total  fatty  acids in the truns fatty  acid diet. 
The percentage of stearic acid was increased on the 
Stearatediet in 55 out of 56 subjects relative to the 
Linoleatediet  (change 0.97 g/100 g; 95% confidence 
interval, 0.86 to 1.09) or to  the  Transdiet  (change 0.88 
g/100  g;  95%  confidence interval, 0.76 to 0.99). Fifty- 
four  out of the 56 subjects showed a larger proportion 
of elaidic acid in their cholesteryl esters when on  the 
Transdiet than when on the Linoleatediet (change 
0.81 g/100 g; 95% confidence interval, 0.70 to 0.92) or 
the  Stearatediet  (change 0.83 g/100 g; 95% con- 
fidence interval, 0.72 to  0.94). All these differences are 
highly significant (P < 0.0001). 
Serum lipids and lipoproteins 
Total and lipoprotein  cholesterol and triglycerides. Table 4 
gives the serum lipid and lipoprotein levels at the end 
of each experimental  diet  period.  Compared with 
levels on  the linoleic acid diet,  serum total cholesterol 
increased by 0.15 mmol/l or 5.8 mg/dl (P = 0.0081; 
95% confidence interval, 0.02 to 0.27 mmol/l)  on  the 
Stearatediet and by 0.16 mmol/l or 6.2 mg/dl (P = 
0.0041; 95% confidence interval, 0.04 to 0.29 mmol/l) 
on  the  Transdiet. LDL cholesterol rose by 0.17 
mmol/l or 6.6 mg/dl (P= 0.0008; 95% confidence in- 
terval, 0.05 to 0.28 mmol/l) on the Stearatediet and 
by 0.24 mmol/l or 9.3 mg/dl (P 0.0001; 95% con- 
fidence interval, 0.12 to 0.35 mmol/l) on the Trans 
diet; this latter value was not significantly greater  than 
the increase on  the  Stearatediet. 
HDL cholesterol decreased by 0.06 mmol/l or 2.3 
mg/dl (P < 0.0001; 95% confidence interval, 0.03 to 
0.10 mmol/l) on the Stearate-diet and by 0.10 mmol/l 
or 3.9 mg/dl ( P <  0.0001; 95% confidence interval, 
0.06 to 0.13 mmol/l) on the Transdiet. Lower HDL 
cholesterol levels on the Transdiet than  on  the 
Linoleatediet were seen in  46 of the 56  subjects (Fig. 
3). The difference of  0.034 mmol/l in  HDL cholester- 
ol between the Stearatediet and the Transdiet just 
failed to reach significance (P = 0.0210; 95% con- 
fidence interval, -0.00 to 0.07 mmol/l). 
The responses of HDL and LDL cholesterol to the 
different diets were correlated  neither with their initial 
levels (day 1) nor with the differences in body weight 
between the dietary regimes. Out of the 12 correlation 
coefficients calculated, the largest observed was -0.24 
(P = 0.08) for  the response in HDL cholesterol versus 
the difference in body weight between the Transdiet 
and the Stearate-diet. 
The HDL to LDL cholesterol ratio was 0.55 on the 
Linoleatediet, 0.50 on the Stearate-diet, and 0.47 on 
the Transdiet; all three values were significantly dif- 
ferent from each other (P< 0.0037 for each com- 
parison). The level  of serum triglycerides was 0.09 
mmol/l or 8.0 mg/dl  higher on the  Stearatediet than 
on  the  Linoleatediet (P = 0.0074; 95% confidence in- 
terval, 0.01 to 0.17 mmol/l). Triglyceride values did 
not differ significantly between the  Transdiet  and  the 
Stearatediet (P = 0.22; 95% confidence interval, 0.04 
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TABLE 3. Fatty acid composition of serum cholesteryl estel-s at the  end of  the three dietary periods 
Fatty  Acid Linoleate-Dirt Strarate-I)ict 7mnel)irl 
c140 
C160" 
C161" 
C18:O 
cis-Cl8:l" 
TransC 18: 1 
Cis, cis-C 1 8: 2" 
C20:4 
Other 
2.71 f 0.85 
8.75 f 0.55 
1.72 f 0.77 
0.77 f 0.1 I 
15.06 f 1.5? 
0.13 f 0.18 
61.01 f 3.926 
6.36 f 1.36 
3.51 f 0.98 
g pm 100 g ofjutty a d s  
2.29f 1.18 
8.37 f 0.64 
1.97 f 0.72 
1.74 f 0.3@ 
20.16 f 1.44 
0.12 f 0.19 
54.41 f 3.23 
6.79 f 1.32 
4.16f0.81 
2.52 f 1.05 
9.10 f 0.64 
2.52 f 0.62 
0.87 f 0.29 
20.62 f 1.40 
0.94 f 0.306 
52.84 f 3.35 
6.42 f 1.05 
4.17 f 0.81 
Values  are means f SD. The 26 men and 30 women consumed each diet for 3 weeks each, in random order. 
"Significantly different between each of the diets, P <  0.02. 
bSignificantly different from both other diets, P <  0.0001. 
to -0.12) or between the  Transdiet and the Linoleate- 
diet ( P  = 0.14; 95% confidence interval, -0.03 to 0.13 
mmol/l) . 
Apolipoproteins. Table 5 shows the mean apo- 
lipoprotein levels and  their ratios at  the end of each 
dietary period. Relative to levels on the  Linoleatediet, 
serum apoB rose by 3.4 mg/dl on the Stearate-diet 
(95% confidence interval, 1.7 to 5.0 mg/dl), and by 
5.0 mg/dl  (95% confidence interval, 3.4 to 6.6 mg/dl) 
on the Transdiet. All three values are significantly dif- 
ferent from each other (P<O.O184 for each com- 
parison).  The apoB to LDL cholesterol ratio was 
essentially the same for each diet. Mean apoA-I level 
was 2.0 mg/dl higher on the Linoleatediet than on 
the Transdiet ( P  = 0.0119; 95% confidence interval, 
0.1 to 4.0 mg/dl).  The difference in serum apoA-I  be- 
tween the Linoleate- and the  Stearatediet periods of 
1.3  mg/dl ( P  = 0.1044; 95% confidence interval, -0.6 
to 3.3 mg/dl), and between the Stearate- and the 
Transdiet periods of 0.7 mg/dl ( P =  0.3586; 95% con- 
fidence interval, -1.3 to 2.7 mg/dl) were not sig- 
nificant. The mean apoA-I to HDL cholesterol (mg/ 
mmol) ratio increased from 856 on  the  Linoleatediet 
to 887 mg/mmol on the Stearate-, and to 904 mg/ 
mmol on the Transdiet ( P  < 0.0081 for each com- 
parison).  The ratio of apoA-I to apoB was 1.85 f 0.36 
TABLE 4. Serum lipid and lipoprotein cholesterol levels at the end of the three dietary periods 
Linoleate-Diet Stearate-Diet Trans-Diet 
mmol per liter 
Total  cholesterol 
Men 4.66 f 0.73 4.93 f 0.82"  4.85 f 0.65" 
Women 
All 
4.81 ? 0.71 4.85 f 0.74 4.95 f 0.78 
4.74 f 0.72 4.89 f 0.77" 4.90 k 0.72" 
Men 1.34 f 0.18 1.28 f 0.17" 1.25 f 0.17" 
Women 1.58 k 0.28 1.52 f 0.26" 1.48 f 0.25" 
All 1.47 f 0.27 1.41 f 0.25" 1.37 + 0.24' 
Men 2.90 f 0.71 3.16 f 0.74" 3.14 f 0.65" 
Women 2.78 f 0.55 2.87 f 0.66 3.01 f 0.66" 
All 2.83 f 0.63 3.00 f 0.71" 3.07 f 0.65" 
Men 0.50 f 0.16 0.44 f 0.14" 0.42 f 0.11" 
Women 0.59 f 0.16 0.56 f 0.16' 0.51 f 0.15"sb 
HDL-cholesterol 
LDL-cholesterol 
HDL/LDL ratio 
All 0.55 f 0.16  0.5  f 0.16"  0.47 f 0.14a,b 
Triglycerides 
Men 0.92 f 0.31 1.07 f 0.41" 1 .OO f 0.35 
Women 0.96 f 0.40 1.01 f 0.36 1.00 f 0.31 
All 0.95 f 0.36 1.04 f 0.38" 1 .OO f 0.32 
values for total, HDL, and LDL cholesterol to mg/dl, multiply by 38.67. To convert values for triglycerides to  mg/dl, multiply 
Values  are means ? SD. The 26 men and 30 women consumed each diet for 3 weeks each, in random order. To convert 
by 88.54. 
"Significantly different from the Linoleatediet, P< 0.02. 
Significantly different from Stearatediet, P < 0.02. 
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Fig. 3. Individual changes in HDL cholesterol levels on diets high in trans fatty acids or stearic acid, relative to a diet high in linoleic acid. 
Bars indicate the level of each individual subject when on  a particular diet minus his or  her level when on the Linoleatediet. 
on  the Linoleate-diet, 1.75 k 0.37 on the Stearate-diet, 
and 1.69 k 0.33 on the Tranpdiet. These values are also 
significantly different from each other (P< 0.0012 for 
each comparison). 
Gender effects. As compared with the Linoleate-diet, 
the mean response of the men on  the Stearate-diet was 
significantly greater  than  that of the women for total 
cholesterol (difference in change, 0.22 mmol/l or 8.5 
mg/dl P = 0.0438) and for apoB (difference in 
change, 3.7 mg/dl; P = 0.0155). The statistical  analyses 
did not reveal  any other significant difference between 
the sexes in the responses of their lipid, lipoprotein, 
or apolipoprotein levels to the diets. 
DISCUSSION 
The  three fatty acids under study  all had 18 carbon 
atoms. Thus effects of the chain length of the fatty 
acids under study on serum lipid and lipoproteins can 
be  excluded. Since the  experimental diets did not 
materially differ in nutrients other than Trans fatty 
acids, stearic acid, and linoleic acid, the changes ob- 
served between the diets must be due to differences in 
the  number  and/or geometry of the  double  bonds in 
these fatty acids. 
Trans fatty acids 
Effects on lipids and lipoproteins. In a previous study 
conducted at  our  department it was found  that 
monounsaturated trans fatty acids at a dose of 11 % of 
energy (on average, 33 g/day) increased LDL choles- 
terol by 14.3 mg/dl (0.37 mmol/l)  and decreased 
HDL cholesterol by 6.6 mg/dl (0.17 mmol/l) as  com- 
pared with the cis isomer, oleic acid (9). However, the 
dose of trans fatty acids consumed probably exceeded 
the range of intakes in  free-living subjects. By contrast, 
the 7.7% of total daily energy intake that was provided 
by the trans fatty acids in the present trial, although 
still higher  than average consumption, may be reached 
by persons who eat large amounts of hardened 
vegetable fats and margarines and of products 
prepared with or fried in such fats (29, 30). Another 
difference with the previous trial was that we now 
studied the effects  of trans fatty  acids  relative to 
linoleic acid. If one assumes that linoleic acid and 
oleic acid differ little in their effects on serum lipids 
when consumed in moderate amounts (31-34), then 
the  magnitude of changes observed here is compatible 
with a linear relation between the dose of trans 
monounsaturates  consumed and  the response of 
serum lipoprotein concentrations. Fig. 4 shows, side- 
by-side, the effects  of monounsaturated trunsC18:l 
fatty acids as observed relative to linoleic acid in the 
present  and relative to oleic acid in the previous study. 
Although more studies are needed to determine the 
true relationship between the dose of  various  types of 
trans fatty acids and their effects on serum lipopro- 
teins, comparison of the results of our two studies sug- 
gests that in our hands  the effects of trans fatty acids 
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TABLE 5. Serum apoA-l and apoB levels and their ratios at the end of the three dietary periods 
Linoleate-Diet Stearate-Diet 7rans-Diet 
mg/dl 
Apolipoprotein A-I 
Men 115.7 f 7.8 115.6 f 8.5 114.9 k 8.4 
Women 131.5f 16.8 129.1 f 13.9 128.4 f 14.6 
All 124.1 f 15.5 122.8 f 13.5 122.1 k 13.8n 
Men 69.5 f 13.3 74.9 i 14.4"  75.4 f 12.7" 
Women 68.8 f 11.5 70.4 + 12.2 73.1 f 12.6a.b 
All 69.1 f 12.2 72.5 f 13.4'  74.  f 12.6",* 
Men 1.73 f 0.38  1.6  f 0.37" 1.57 k 0.32" 
All 
Women 1.95 + 0.31  1.88 f 0.33"  1.80 k 0.31aab 
1.85 ? 0.36  1.75 f 0.37"  1.69 f 0.33"jb 
Values are means? SD. The 26 men  and  30  women  consumed  each  diet for 3 weeks each,  in  random order. 
Significantly  different from the  Linoleatediet, P < 0.02. 
bSignificantly different from the  Stearatediet, P < 0.02. 
Apolipoprotein B 
Apolipoprotein A-I/B  ratio 
on LDL and HDL cholesterol are  proportional to the 
amounts consumed. 
The trans fatty acids supplied to our subjects con- 
sisted largely of C18:l(n-9) (elaidic acid), with traces 
of C18:l(n-8) and C18:l(n-10). These are also the 
predominant trans  fatty acids produced by hydrogena- 
tion of vegetable oil in food manufacturing (2, 35) .  
The spectrum of trancC18:l positional isomers con- 
sumed by the subjects in our previous trial was much 
broader (9, 22). Nevertheless, the observed effects in 
both trials  were  largely congruent if the differences in 
dose are taken into account. We therefore think that 
rnmol/L mo/dL 
1 -  I 
I A LDL CHOLESTEROL T /  
, 
Zock 8 Katnn 1992 
0 
ENERGY % TRANS-C18 1 
1-15 
l 1 0  
1 5 0 -5 -10 
Fig. 4. Effects of trans fatty acids on LDL and HDL cholesterol in 
the present trial compared with those in a previous trial. Circles 
represent data  from a comparison of transC18:l with oleic  acid (9). 
Squares are based on the present comparison between transC18:l 
and linoleic acid. Bars denote 95% confidence intervals. In addi- 
tion to the two experiments, the origin provides a third point, be- 
cause a zero change in  i take will produce  zero  change in 
lipoprotein  levels. 
our findings will apply to most monounsaturated trunc 
C18:l fatty acid isomers as present in commercial fats 
and foods. 
Public  health  implications.  Based on  our two studies as 
summarized in Fig. 4, it can be speculated that one 
dietary energy % of trans  fatty  acids  in the  diet raises 
LDL cholesterol by about 1.2 mg/dl (0.03 mmol/l) 
and lowers  HDL cholesterol by about 0.6 mg/dl (0.015 
mmol/l) relative to oleic or linoleic acid. The  current 
average  trans intake of 3-4% of energy in the United 
States might thus cause an elevation  of LDL cholester- 
ol by about  4  mg/dl  and  a depression of HDL choles- 
terol by about 2 mg/dl relative to eisunsaturates. 
Although these figures appear modest, the predicted 
effect on HDL cholesterol is  of the same magnitude as 
the difference in HDL cholesterol between physically 
active and sedentary people (36) or between in- 
dividuals at  the  10th  percentile of  body  mass index ver- 
sus those at  the 50th percentile (3'7). For comparison, 
smoking 10 cigarettes per day will, on average, lower 
HDL cholesterol by about 2-4 mg/dl (38). 
What would be the predicted effect on coronary 
heart disease risk if the average trans fatty acids con- 
sumption of 7 to 10 g/day in the United States popula- 
tion were to be completely replaced by oleic and 
linoleic acid? Both epidemiological data  and results of 
controlled trials  suggest that  the predicted decrease of 
4  mg/dl in LDL cholesterol should lead to a decrease 
in the average risk for coronary heart disease of 3%. 
The increase of 2 mg/dl in HDL cholesterol should 
add another 4 5 %  reduction in risk (39, 40). Total 
risk reduction should thus average 7-8%, provided 
that raising HDL indeed reduces risk,  which is a plaus- 
ible but still unproven assumption (39). A reduction in 
risk  of this magnitude does  not  appear to justify total 
elimination of partially hydrogenated oils from the 
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United States food supply, especially since a sizeable 
part of current trans fatty acid intake is supplied by 
dairy and beef fat. However, it is  possible that selected 
individuals consume considerably higher amounts of 
trans fatty acids than  the average of 3 4 %  (41),  and for 
them  the effects  of trans fatty acids can be of clinical 
importance. Obviously, the trans fatty acid intake of 
various segments of the population needs to be a s  
sessed, and groups with high  intake  need  to be iden- 
tified. Even the average intake in the  United States is 
controversial, with quoted figures ranging from 8 to 15 
g/day (30).  The estimate of 17 g/day for  the Nether- 
lands (42) is similarly  based on incomplete  data and a 
host of assumptions. Better intake data are thus ur- 
gently needed before any public health measures at 
curbing trans intake can even be  considered. 
Stearic  acid 
Recent studies (31-34) suggest that the effects of 
linoleic acid and oleic acid on serum total and LDL 
cholesterol levels are  more similar than previously o b  
served (1 1, 12). Stearic acid has also repeatedly been 
reported  to  produce  serum lipid levels similar to those 
seen on oleic acid (11-14). Thus, one would expect 
stearic acid and linoleic to  be  more or less equivalent 
with respect to their cholesterolemic effect. This was 
indeed observed for the women in our study, but  not 
for  the  men, who showed a small but significant rise in 
total and LDL cholesterol and triglycerides on the 
Stearate- versus the  Linoleatediet. The increase of 
10.4 mg/dl (0.27 mmol/l) in total cholesterol is in 
line with the  equations of  Keys, Anderson, and  Grande 
(1 1) and Hegsted et al. (12), which predict an increase 
of  9.7-11.6 mg/dl in men when 8 dietary energy % of 
linoleic acid is replaced by stearic or oleic acid. In  the 
absence of an oleic acid diet period in the present 
trial, it is impossible to tell whether  the difference in 
cholesterol levels in males of 10.4 mg/dl between the 
Stearate- and  Linoleatediet  periods was due to stearate 
being somewhat cholesterol-raising or linoleate being 
somewhat cholesterol-lowering relative to oleic acid. 
Whatever the relative effects of stearate, oleate, and 
linoleate, they are much smaller than  the 28.6 mg/dl 
(0.74 mmol/l) increase that  can  be  predicted  for  a re- 
placement of 8 dietary energy % of linoleic acid by a 
mixture of lauric (C12:0), myristic (C14:0), and pal- 
mitic (C16:O) acids ( l  l).  Obviously, stearic acid raises 
total and LDL cholesterol less than other saturated 
fatty acids, and it will probably take a  number of  very 
large trials to tell whether the effects of stearic and 
oleic acid differ at all. 
Our data do suggest that stearic acid might have 
some HDL cholesterol-lowering potential relative to 
linoleic acid, 0.06 mmol/l or 2 mg/dl in the present 
study. In the study of Bonanome and Grundy (14) a 
diet  enriched with 16 energy % from stearic acid 
resulted in  HDL  levels that were 3.9 mg/dl (0.10 
mmol/l) lower than those on a diet enriched with 
oleic acid. This difference was not statistically  sig- 
nificant, but at the very least the observations of 
Bonanome and Grundy (14) on stearic acid and HDL 
do not contradict ours. Becker et al. (43) compared 
the effects of saturated fat versus monounsaturated 
and polyunsaturated fat. Their  saturated fat diet sup- 
plied 12-13 energy % from stearic acid as opposed to 
1 energy % in the two other diets. The stearate-rich 
saturated fat diet decreased HDL cholesterol by 0.10 
mmol/l compared with the monounsaturated and by 
0.14 mmol/l compared with the polyunsaturated fat 
diet. As in the study of Bonanome  and Grundy (14), 
these differences were not statistically significant. 
Nevertheless, data from both studies are in line with 
our present observations, and they suggest that stearic 
acid may be neutral as regards total but  not HDL cho- 
lesterol. The potential HDL cholesteroldepressing ef- 
fect of stearic acid obviously needs  more study. 
Effect  of  gender on responses  of  lipid and 
lipoproteins  to  diet 
Suitability offemales f i  studies on diet and lipids. Most 
trials on the effects  of diet on serum lipid and lipopro- 
tein levels  have used men only, partly because 
coronary heart disease was considered primarily a 
male disease, but partly also because women  were con- 
sidered less suitable because of confounding effects  of 
the menstrual cycle. In fact, different studies on  the in- 
fluence of the  natural menstrual cycle on serum lipids 
show different effects (44, 45) or only minor if any  ef- 
fects (46),  and a recent textbook concluded “the de- 
gree of variation observed is  relatively  small and results 
of separate studies have sometimes been inconsistent” 
(47). However, oral contraceptives do influence the 
concentrations of total and HDL cholesterol in a cycli- 
cal manner (46). At first sight one might think that 
this might confound our findings in the 13 women 
who  used oral contraceptives. This, however, is not  the 
case. Different women entered the study at different 
points in their cycle, and in addition, diets were fed in 
random  sequence, so that  the effects  of the contracep- 
tive  cycle canceled each other  and averaged out.  Thus, 
any  woman  who had  an unusually low HDL cholester- 
ol during week 3 of the Linoleate-diet because she was 
at  he end of her cycle  was counterbalanced on 
average by another woman  whose  HDL cholesterol was 
high when she was at week 3 of the Linoleate-diet be- 
cause she  happened to be at  the pill-free period of her 
cycle. 
Unlike the means, one would expect the standard 
deviations of the responses to be biased upwards be- 
cause cyclic  effects add  a  random positive or negative 
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term to each lipid data  point. The standard deviations 
of the responses to dietary changes of the women 
using oral contraceptives were indeed somewhat larger 
than those of the women not using contraceptives (on 
average 0.43 mmol/l vs. 0.28 mmol/l for LDL choles- 
terol, and 0.15  mmol/l vs. 0.10 mmol/l for HDL cho- 
lesterol). However, standard deviations of the mean 
responses of  all  30 women combined (1 3 users plus 17 
non-users) were very similar to those of the 26 men 
(on average 0.38 vs. 0.34 mmol/l  for LDL and 0.13 vs. 
0.09 mmol/l for HDL cholesterol). This is in accord 
with our previous experience (18, 32). This would 
seem to validate the use of female volunteers as ex- 
perimental subjects in studies of diet and lipids; at the 
very most, the  number of females required to reach a 
certain statistical power should be adjusted upward 
when the majority are using oral contraceptives. 
Gender effects on response. We found  no differences be- 
tween men and women in the response of serum lipo- 
protein or apolipoprotein levels to the trans fatty acid 
diet relative to linoleic acid (Tables 4 and 5). In a pre- 
vious study the effects of replacing oleic acid by trans 
fatty acids were  also similar in men and women (9). It 
therefore appears that the lipoprotein levels of men 
and women respond similarly to dietary trans fatty 
acids. 
The increase in total and LDL cholesterol and 
triglycerides in men on the Stearate-diet was not ob- 
served for the women in our study (Table 4). Com- 
pared with the Linoleate-diet, the changes of the 
men’s total cholesterol and apoB levels on  the 
Stearate-diet were  significantly larger than those of the 
women (Tables 4 and 5). HDL cholesterol was 
decreased to a similar extent in men and women. The 
HDL/LDL ratio was significantly lowered on  the 
Stearate-diet versus the Linoleate-diet in  both men and 
women, although  the effect was  very small in the 
women (Table 4). Whether stearic acid is cholesterol- 
raising in men  but not in women could not be defini- 
tively addressed here. Obviously this point  needs 
further investigation. 
Consequences €or the  production of hardened fats 
Replacement of 8 dietary energy % of monoun- 
saturated trans fatty acids by stearic acid resulted in 
only minor changes in serum lipid and lipoprotein 
values. Our  data  thus do not  support  the idea that in- 
creasing the stearic acid content of hardened fats at 
the expense of trans fatty acids is beneficial for the 
serum lipid profile; either  mode of hydrogenation 
produced fatty acids that increased LDL and 
decreased HDL cholesterol relative to linoleic acid it- 
self. 
However, trans fatty acids and stearic acid probably 
raise total and LDL cholesterol to a lesser extent  than 
C12-16 saturated acids. Even if the trans fatty acids 
408 Journal of Lipid Research Volume 33, 1992 
were to be equated with C12-16 saturated acids be- 
cause of their added unfavorable effect on HDL, thc 
content of trans plus cholesterol-raising saturates in 
butter still far exceeds that in  soft margarines. Butter is 
also very high in cholesterol. Therefore, replacement 
of butter by soft margarines remains of value in the 
dietary treatment of hypercholesterolemia. However, 
manufacturers  should  consider  the  option of produc- 
ing soft margarines free of trans fatty acids. Diet mar- 
garines with zero trans fatty acids made from 
unmodified sunflower oil and a small amount of‘ a 
stearate-rich hard stock (48) have been marketed suc- 
cessfully for many years in  Europe and  are also avail- 
able in North America. 
Although data on the trans fatty  acid content of 
brick margarines, vegetable shortenings, and solid 
vegetable frying  fats are  incomplete, it is probably 
much  higher  than in soft margarines, and the sum of 
trans fatty acids and cholesterol-raising saturates in 
such fats may approach  that in beef tallow or lard. If 
the unfavorable effects of trans fatty acids on serum 
lipoproteins  are  borne out by future studies, then  the 
use of so-called “cholesterol-free” solid vegetable fats 
for cooking or (deep-fat) frying may offer few health 
benefits over beef tallow or lard,  and  at  that time re- 
placement of such fats by unmodified or very lightly 
hydrogenated oils should be considered. Use of high- 
trans fats could then be limited to baked goods and 
other  products where suitable replacements  are much 
harder to find. 
However, any large-scale displacement of partially 
hydrogenated vegetable oils from the market should 
await the outcome of further experiments, which in 
addition to lipids should also attempt to gauge effects 
on fibrinogen and on platelet function and aggrega- 
tion tendency. I 
We are indebted to the  members of our technical  and 
dietary staff, especially Ms. Jeanne H. M. de Vries, R.D., Ms. 
Margriet Penders, MSc., and to Dr. Ronald P. Mensink for 
their help  and  advice;  to  the  subjects  for  their  cooperation 
and interest; to Dr. Martin Sandkamp and Prof. Dr. Gerd 
Assmann,  Institut  fur  Klinische  Chemie  und  Labora- 
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